Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$5.65 - $7.66 $232,780 - $315,592
-41,200 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.01 - $6.29 $85,012 - $133,348
21,200 Added 106.0%
41,200 $232,000
Q2 2020

Aug 14, 2020

BUY
$3.06 - $6.6 $61,200 - $132,000
20,000 New
20,000 $102,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Symmetry Peak Management LLC Portfolio

Follow Symmetry Peak Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Peak Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Peak Management LLC with notifications on news.